Janux Therapeutics, Inc. — All Filings
408 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
144/A
3
3/A
4
4/A
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
EFFECT
FWP
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| S-8 | S-8 | 0001193125-26-076970 | Feb 26, 2026 | — |
| 10-K | 10-K | 0001193125-26-076918 | Feb 26, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001193125-26-076627 | Feb 26, 2026 | — |
| SCHEDULE 13G | — | 0001104659-26-011545 | Feb 6, 2026 | — |
| 4 | — | 0002108554-26-000004 | Feb 4, 2026 | Feb 2, 2026 |
| 3 | — | 0002108554-26-000003 | Feb 4, 2026 | Jan 26, 2026 |
| 144 | — | 0001950047-26-000670 | Jan 26, 2026 | — |
| 144 | — | 0001950047-26-000654 | Jan 23, 2026 | — |
| 8-K | 8-K | 0001193125-26-019520 | Jan 22, 2026 | Jan 21, 2026 |
| SCHEDULE 13G/A | — | 0000315066-26-000045 | Jan 8, 2026 | — |
| 4 | — | 0001864159-26-000002 | Jan 2, 2026 | — |
| 4 | — | 0002005618-26-000002 | Jan 2, 2026 | — |
| 4 | — | 0001864158-26-000002 | Jan 2, 2026 | — |
| 4 | — | 0001960264-26-000002 | Jan 2, 2026 | — |
| 4 | — | 0002050056-26-000002 | Jan 2, 2026 | — |
| 4 | — | 0002069239-26-000002 | Jan 2, 2026 | — |
| 4 | — | 0002032671-26-000002 | Jan 2, 2026 | — |
| 144 | — | 0001950047-25-010281 | Dec 15, 2025 | — |
| 144 | — | 0001950047-25-009961 | Dec 8, 2025 | — |
| 4 | — | 0001864159-25-000006 | Dec 3, 2025 | Dec 1, 2025 |
| 144 | — | 0001950047-25-009650 | Dec 2, 2025 | — |
| 144 | — | 0001950047-25-009526 | Dec 1, 2025 | — |
| 4 | — | 0001864159-25-000005 | Nov 14, 2025 | — |
| 144 | — | 0001950047-25-008864 | Nov 14, 2025 | — |
| 10-Q | 10-Q | 0001193125-25-269799 | Nov 6, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001193125-25-269518 | Nov 6, 2025 | — |
| 4 | — | 0001864159-25-000003 | Oct 30, 2025 | Oct 28, 2025 |
| 144 | — | 0001950047-25-008226 | Oct 28, 2025 | — |
| 8-K | 8-K | 0001193125-25-209259 | Sep 19, 2025 | Sep 18, 2025 |
| SCHEDULE 13G/A | — | 0001104659-25-078664 | Aug 14, 2025 | — |
| SCHEDULE 13G/A | — | 0000902664-25-003510 | Aug 12, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-105069 | Aug 7, 2025 | Jun 30, 2025 |
| 8-K | 8-K | 0000950170-25-105010 | Aug 7, 2025 | — |
| SCHEDULE 13G | — | 0002052113-25-003076 | Jul 17, 2025 | — |
| 4 | — | 0001415889-25-017318 | Jun 13, 2025 | Jun 11, 2025 |
| 4 | — | 0001415889-25-017317 | Jun 13, 2025 | Jun 11, 2025 |
| 4 | — | 0001415889-25-017316 | Jun 13, 2025 | Jun 11, 2025 |
| 4 | — | 0001415889-25-017315 | Jun 13, 2025 | Jun 11, 2025 |
| 4 | — | 0001415889-25-017314 | Jun 13, 2025 | Jun 11, 2025 |
| 4 | — | 0001415889-25-017313 | Jun 13, 2025 | Jun 11, 2025 |
| 4 | — | 0001415889-25-017312 | Jun 13, 2025 | Jun 11, 2025 |
| 4 | — | 0001415889-25-017311 | Jun 13, 2025 | Jun 11, 2025 |
| 4 | — | 0001415889-25-017310 | Jun 13, 2025 | Jun 11, 2025 |
| 8-K | 8-K | 0000950170-25-086284 | Jun 13, 2025 | Jun 11, 2025 |
| 4 | — | 0001415889-25-015684 | Jun 4, 2025 | Jun 2, 2025 |
| 3 | — | 0001415889-25-014557 | May 23, 2025 | May 14, 2025 |
| 10-Q | 10-Q | 0000950170-25-067083 | May 8, 2025 | Mar 31, 2025 |
| 8-K | 8-K | 0000950170-25-066969 | May 8, 2025 | — |
| 4 | — | 0001415889-25-011874 | May 2, 2025 | May 1, 2025 |
| 144 | — | 0001950047-25-002662 | May 1, 2025 | — |